Wintrust Financial Corporation »

Protagonist Therapeutics shares owned by Wintrust Financial Corporation

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Wintrust Financial Corporation from 13F filings

Historical chart of Wintrust Financial Corporation investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Wintrust Financial Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 91k 22.93
2023-09-30 $2.4M 142k 16.68
2023-06-30 $4.1M 147k 27.62
2023-03-31 $3.5M 151k 23.00